Global Clinical Trials Supply & Logistics for Pharmaceutical Market to reach $30.59 Billion by 2027 at a CAGR of 7.69%

company logo

company logo

Global Clinical Trial Supply & Logistics for the Pharmaceutical Market

Logistics for the Global Clinical Trial Supplies & Pharmaceutical Market

Global Clinical Trial Supply & Logistics for the Pharmaceutical Market

DUBLIN, July 28, 2022 (Globe Newswire) — The “Clinical Trial Supply and Logistics for Pharmaceutical Market Research Report by Phase (BA/BE Studies, Phase I, and Phase II), Sectors, Therapeutics, Regions (America, Asia-Pacific and Europe, Middle East and Africa) – Global 2027 Forecast to – Cumulative impact of COVID-19” report has been added’s Presentation.

The Global Clinical Trials Supply & Logistics for pharmaceutical market size is estimated at USD 18,213.74 million in 2020, USD 19,607.86 million in 2021, and expected to grow at a Compound Annual Growth Rate (CAGR) of 7.69% to reach USD 30,593.72 million by 2027 Have an estimate. ,

market dynamics

  • Increase in R&D expenditure of the pharmaceutical and biopharmaceutical industry

  • Increased focus on drug development

  • Globalization of clinical trials and harmonization of regulations



  • Outsourcing of clinical trial activity

  • Increased focus on generics and biologics

  • Regulatory approval in emerging markets


Market Segmentation and Coverage:
This research report classifies clinical trial supply and logistics for pharmaceutical in order to forecast revenue and analyze trends in each of the following sub-markets:

  • On a Phase I basis, the market was studied in BA/BE studies, Phase I, Phase II, Phase III and Phase IV.

  • Based on the sector, market studies were conducted in Clinical Trial Logistics & Distribution, Clinical Trial Manufacturing Services, and Clinical Trial Supply Chain Management.

  • On the basis of therapeutic area, the market was studied in Blood Disorders, Digestive System Diseases, Infectious and Immune System Diseases, Neurological & Mental Disorders, and Oncology.

Competitive Strategic Window:
The competitive strategic window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt gradual merger and acquisition strategies, geography expansion, research and development, and new product introduction strategies to execute further business expansion and growth during the forecast period.

FPNV Positioning Matrix:
FPNV positioning metrics for the pharmaceutical market based on business strategy (business growth, industry coverage, financial viability, and channel support) and product satisfaction (value for money, ease of use, product) of vendors in clinical trial supplies and logistics Evaluates and categorizes features, and customer support) that help businesses make better decisions and understand the competitive landscape.

Market Share Analysis:
Market share analysis provides analysis of sellers considering their contribution to the overall market. It provides the idea of ​​its revenue generation in the overall market as compared to other vendors in the space. It provides insight into how vendors are performing in terms of revenue generation and customer base as compared to others. Knowing the market share gives an idea of ​​the size and competition of sellers for the base year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and amalgamation traits.

competitive landscape:
The competitive landscape provides a perspective analysis of the various business development strategies adopted by the vendors. The news stories covered in this section provide valuable ideas at various stages while staying up-to-date with the business and engaging stakeholders in the economic debate. The competitive landscape represents press releases or news of companies classified into mergers and acquisitions, agreements, collaborations, and partnerships, new product launches and promotions, investments and funding, and awards, recognition, and expansion. All the news gathered helps the seller to understand the gaps in the market and the strength and weakness of the competitor, thereby providing insights to enhance the product and service.

Major topics covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Clinical Trial Supply and Logistics for the Pharmaceutical Market, by Phase

7. Clinical Trial Supplies and Logistics for the Pharmaceutical Market, by Sector

8. Clinical Trial Supply and Logistics for the Drug Market by Therapeutic Sector

9. Americas Clinical Trials Supply and Logistics for the Pharmaceutical Market

10. Asia-Pacific Clinical Trial Supply and Logistics for the Pharmaceutical Market

11. Europe, Middle East and Africa Clinical Trials Supplies and Logistics for the Pharmaceutical Market

12. Competitive Landscape

13. Company Utility Profile

14. Appendix

mention of companies

  • Almac Group

  • Bilcare Limited

  • Biocare International Limited

  • Catalent, Inc.

  • Clinigen Group Plc

  • DHL International GmbH by Deutsche Post AG

  • Eurofins Scientific SE

  • fedex corporation

  • Icon PLC

  • Infosys Limited

  • Cliffo A/S

  • Lonza Group

  • Base

  • Matrix Contract Services by Maine Pharma Group

  • moving

  • n-side

  • PCI Pharma Services

  • Parexel International Corporation

  • Siro Cleanpharm Private Limited

  • Seveillar Diagnostic Trial Supplies Pvt. Ltd.

  • Thermo Fisher Scientific, Inc.

  • UDG Healthcare Plc

  • World Courier Management Inc.

For more information about this report, visit


CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Reply

Your email address will not be published.